Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Vocabria, cabotegravir, Date of authorisation: 17/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 3, Status: Authorised

EMA multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2024 to 17 April 2024

EMA multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2024 to 17 April 2024

Human medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 8, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.